Journal of the advanced practitioner in oncology最新文献

{"title":"Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program.","authors":"Michael Tarantino, David Dubinski, Corey Falcon, Leslie Ferber, Patrick Foy, Stephanie Johnston, Susan Kirk, Michele P Lambert, Farishta Manzoor, Vlad Radulescu, Iberia Romina Sosa, Porcher Scott","doi":"10.6004/jadpro.2026.17.7.7","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.7.7","url":null,"abstract":"<p><strong>Background: </strong>Immune thrombocytopenia (ITP) is a rare autoimmune disorder resulting in reduced platelet count. The annual incidence is 3.3 per 100,000 adults and 8.8 per 100,000 person-years in children. Immune thrombocytopenia impacts the quality of life, productivity, and psychosocial well-being of patients and caregivers. This quality improvement study aims to characterize needs of patients, caregivers, and health-care providers (HCPs) managing chronic ITP to improve management in the future.</p><p><strong>Methods: </strong>We conducted a two-session Learning Exchange program: one with HCPs and adult patients, and one with HCPs and caregivers of pediatric patients. Discussions encompassed clinical and personal experiences with chronic ITP, the health-care system, and support resources. Session transcripts identified key themes, which participants subsequently prioritized in a post-meeting survey.</p><p><strong>Results: </strong>A total of 7 patients, 6 caregivers, and 14 HCPs participated in the Learning Exchange sessions, discussing challenges in chronic ITP management and areas for improvement. Post-meeting surveys identified shared priorities, ranked as follows: (1) empowering patients to self-advocate; (2) strengthening shared decision-making; (3) improving resources and support; (4) following the evolving treatment landscape; and (5) mental health support.</p><p><strong>Conclusions: </strong>The sessions identified key needs involving improved education for patients, caregivers, and HCPs; improved communication between patients, caregivers, and HCPs; the greater need for self-advocacy and shared decision-making; and the desire for better support resources and networks. This knowledge will enable the development of improved educational resources, support programs, and future research to benefit the chronic ITP community and improve the quality of management of chronic ITP for patients, caregivers, and HCPs.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-13"},"PeriodicalIF":0.0,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advanced Practice Providers in Oncology Care: Consensus Principles for Clinical Practice Utilization.","authors":"Dori L Klemanski, Terry Harrington, Lindsey Bandini, Kari Castillo, Michelle Gulbrandson, Amy Kjeldahl, Kevin Krise, Brighton Loveday, Todd Pickard","doi":"10.6004/jadpro.2026.17.7.9","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.7.9","url":null,"abstract":"<p><p>Advanced practice providers (APPs) play a critical role in delivering high-quality patient-centered care within oncology. The National Comprehensive Cancer Network Best Practice Committee's APP workgroup generated consensus principles to optimize the potential of APPs, promote professional growth, foster interdisciplinary collaboration, and establish APP leadership structures within organizations to meet the evolving demands of oncology care. This article outlines the stepped approach to develop consensus-based principles to enhance the effectiveness of APPs providing oncology care.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Promise of Artificial Intelligence to Aid in Systematic Reviews: An Examination of Scopus AI.","authors":"Lydia T Madsen, John C Carter, Sheeba Cantanelli, Christine Hong, Angela Bazzell","doi":"10.6004/jadpro.2026.17.7.10","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.7.10","url":null,"abstract":"<p><p>Systematic reviews are a critical tool in oncology practice to facilitate informed clinical decision-making, synthesize current research, and guide practice policy. To facilitate early exploration of a literature query or topic, Scopus Artificial Intelligence (AI), which was introduced in 2024 and is subscription-based, provides a new tool for researchers and providers to access current data or begin a systematic review topic exploration. The following article is intended to familiarize advanced practice providers (APPs) with both the recently released AI tool of Scopus AI and associated AI interface capabilities with literature search methodologies. Scopus AI is embedded within the extensive resources of Scopus, an established search engine database. Scopus AI simplifies a topic search by allowing a user to enter the question or phrase in natural language, or ordinary spoken or written language. It then translates the query into a vector and/or keyword search. Scopus AI summarizes the output results to include bullet points, numbered highlights, and conclusions. Associated citations, with internal URL links to articles embedded within the Scopus database, allow for confidence in the output summary. Pivotal or landmark study foundational document citations are also listed. The utilization of AI tools can aid APP researchers and clinicians to expedite steps in the systematic review process. Multiple tools are available to assist the researcher; Scopus AI is one of the tools that can be used to assist in streamlining specific aspects such as the initial tasks and literature search steps of the systematic review development process.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance.","authors":"Kimberly Noonan, Kevin Brigle, Charise Gleason, Carrie Bellerive, Mary Steinbach, Deborah Doss","doi":"10.6004/jadpro.2026.17.7.11","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.7.11","url":null,"abstract":"<p><p>Monoclonal gammopathy of undetermined significance (MGUS) is characterized as a nonmalignant or premalignant state whereby monoclonal immunoglobulins are detected in plasma, urine, or both. Approximately 3% to 4% of the population over the age of 50 is diagnosed with MGUS. It is estimated that 1% will progress to multiple myeloma or lymphoma over 20 years and therefore require ongoing clinical monitoring. Monoclonal gammopathy of undetermined significance is categorized into three types that are determined by the paraprotein clone: immunoglobulin M (IgM) MGUS, non-IgM MGUS, and light chain MGUS. There are high-risk genetic, biochemical, and clinical factors that increase the risk of transformation to multiple myeloma or lymphoma. The incidence of MGUS is two- to threefold higher in the Black population compared with the White population, along with an earlier age of onset. Familial risk and modifiable lifestyle factors are also associated with the development of MGUS and multiple myeloma. Certain monoclonal gammopathies, known as monoclonal gammopathy of clinical significance (MGCS), are associated with various organs that are involved (kidney, brain, skin, lungs, liver, eyes, and heart). The most common MGCS are associated with renal and neurological abnormalities, and treatment may be considered. Early diagnosis and multidisciplinary approaches to mitigate organ damage and other complications are important for the recognition and management of MGCS. Monoclonal gammopathy of undetermined significance is monitored rather than treated unless there are clinical findings of progression or organ dysfunction. Ongoing research and clinical trials are essential to refine monitoring guidelines, develop targeted therapies, and explore preventive measures aimed at reducing progression to multiple myeloma and other malignancies.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities.","authors":"Brett S Wagner, Levi Martinka, Drew Gordon, Sarah Anderson, Katherine Bukolt, Kate Martin, Daniel W Golden","doi":"10.6004/jadpro.2026.17.7.8","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.7.8","url":null,"abstract":"<p><strong>Purpose/objective: </strong>Advanced practice providers (APPs), including physician associates (PAs) and nurse practitioners (NPs), are increasingly utilized in radiation oncology. However, radiation oncology-specific training for APPs is not standardized. This study elucidates the current role of US radiation oncology APPs by assessing clinical responsibilities.</p><p><strong>Methods: </strong>Radiation oncology APPs in the US were sent a survey examining demographics, training, practice structure, and clinical tasks using the framework of the 52 entrustable professional activities (EPAs) developed by the Radiation Oncology Education Collaborative Study Group (ROECSG).</p><p><strong>Results: </strong>37 PAs and 84 NPs participated. 53.7% practiced a different specialty previously. 63.6% had three or more APPs in the department, and 71.9% covered multiple physicians. 65.3% worked in a practice alongside radiation oncology residents, and 79.7% of these APPs worked directly with residents. 25.6% performed procedures. 95% completed follow-up/survivorship visits, 71% completed acute symptom visits, 65% completed ambulatory consults, 45% completed inpatient consults, and 38% completed on-treatment visits. 21.5% specialized in one disease site, 39.7% covered multiple disease sites, and 38.8% covered all disease sites. 22 of 52 ROECSG EPAs were performed by > 90% in some capacity. > 90% did not complete EPAs 15, 32, 33, 35, 36, 37, 38, 40, and 46. Only 2.5% of APPs received formal radiation oncology training during APP education.</p><p><strong>Conclusions: </strong>APPs perform many ROECSG EPAs, primarily during follow-up/survivorship visits. However, job responsibilities vary widely across radiation oncology clinics. Further definition of the APP role is essential to meet the growing demands of cancer care, support the evolution of radiation oncology, and enhance patient care.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-10"},"PeriodicalIF":0.0,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064866/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Many Titles, One Mission: Advancing Team-Based Care in Oncology.","authors":"Beth Faiman","doi":"10.6004/jadpro.2026.17.2.1","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.2.1","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"17 2","pages":"49-50"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perceptions of Quality of Life for Women Pregnant During a Cancer Diagnosis: A Review of the Literature.","authors":"Ashley Martinez, Nina Fredland","doi":"10.6004/jadpro.2026.17.2.3","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.2.3","url":null,"abstract":"<p><p>Given the current trend of delaying pregnancy and the gradual increase in age-related risk of certain cancers, the incidence of pregnancy during a cancer diagnosis will likely continue to increase. The objective of this review is to identify specific aspects of quality of life that impact women diagnosed with a cancer during pregnancy. A comprehensive search was conducted using PubMed and Health Research Premium databases, including articles from 2014 to 2024 that assessed psychological or quality-of-life outcomes in cancer during pregnancy. A total of 1,987 articles were screened with a final yield of six articles that met the inclusion criteria. Overall, themes included fear and worry, social support, and concerns over breastfeeding. These themes were identified as aspects of quality of life that impact women diagnosed with cancer during pregnancy. It is critical that all members of the health-care team recognize the unique situation that occurs when a pregnancy is complicated by a cancer diagnosis.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"17 2","pages":"66-74"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Blazing Trails With Research: Paving the Way for Advanced Practice Providers.","authors":"Carlin Callaway, Katie Hogan, Victoria Jennrich, Allison Poore","doi":"10.6004/jadpro.2026.17.2.4","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.2.4","url":null,"abstract":"<p><strong>Introduction: </strong>In September 2021, the National Cancer Institute (NCI) expanded the ability for advanced practice providers (APP) to practice more autonomously by being able to write orders for research-related anti-cancer therapy.</p><p><strong>Objectives: </strong>The goal was to align with NCI guidance to permit APPs to independently write non-Cycle 1 Day 1 study agent orders.</p><p><strong>Methods: </strong>An academic institution created a process to comply with the NCI's memorandum. Health-system policy was updated to reflect this new capability. A tracking system was established to monitor NCI's Registration and Credentialing Roster (RCR) expiration dates. An audit process was created to verify alignment between signed electronic research-related anti-cancer therapy orders and Delegation of Tasks Logs.</p><p><strong>Results: </strong>To date, no adverse comments about APPs' abilities to sign anti-cancer trial orders have been received from organizations that accredit or support clinical trials. In addition, no APPs have lost the ability to sign anti-cancer therapy orders because they failed to renew their RCR within the expiration period. To facilitate this capability in a timely manner, a research-specific onboarding experience was created.</p><p><strong>Conclusion: </strong>APPs may safely write anti-cancer treatment orders for patients enrolled in clinical trials. Additionally, such privilege may contribute to the enhanced participation of APPs through research.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"17 2","pages":"75-80"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer.","authors":"Amy Hacker-Prietz, Mary-Eve Brown, Laurie Singer, Amol Narang, Priya Pathak, Carrie Stricker, Joseph Herman","doi":"10.6004/jadpro.2026.17.2.2","DOIUrl":"https://doi.org/10.6004/jadpro.2026.17.2.2","url":null,"abstract":"<p><p>Pancreatic cancer carries poor overall survival. A high percentage of patients with pancreatic cancer experience a significant amount of weight loss at the time of diagnosis even before starting treatments. Nutritional status and maintaining proper nutrition can be extremely challenging due to multiple factors. Malnutrition can lead to a poorer quality of life, worsening of symptoms, and inability to complete planned treatments, leading to worse clinical outcomes. Evaluating nutritional status and implementing a plan early is essential. Having a good multidisciplinary team and partnering with a registered dietitian should be an integral part of patient care. Nutrition education for clinical teams, patients, and caregivers can help keep patients feeling better and on track with care. Patients should be screened early and routinely for malnutrition, dehydration, and exocrine pancreatic insufficiency. Managing side effects of the disease and engaging patients' caregivers are important to maintaining good nutrition and improving quality of life.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"17 2","pages":"56-65"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13064575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Narrative Medicine: A Clinical Tool for the Oncology Advanced Practitioner.","authors":"Jonathan Cunningham","doi":"10.6004/jadpro.2026.17.7.4","DOIUrl":"10.6004/jadpro.2026.17.7.4","url":null,"abstract":"<p><p>Narratives are central to the practice of medicine. However, modern health care faces numerous new demands, including increased patient loads and professional commitments, which interfere with opportunities to listen to and tell stories. These challenges can negatively impact patient care and provider burnout. Narrative medicine has been proposed as an approach to overcome these difficulties. Through implementation of this technique, engaging with illness anecdotes can become a more integral clinical focus. Its main movements are attention, reflection, and affiliation. There are multiple styles proposed for its use, although they all assist in the exploration of meaning within illness narratives. Over the past several decades, a shift toward promoting these tools has led to more research in the field. Multiple studies demonstrate the benefits to patients, providers, and caregivers. Additionally, programs are expanding to further the development of these skills. With guidance and repetition, these abilities can foster better engagement and understanding between all those involved in health care. This article discusses the various principles of narrative medicine and the benefits of its incorporation into health care, specifically in the role of oncology advanced practitioners.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12897419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146204485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}